Mankind Pharma IPO Subscription Status [ Final ]

The Mankind Pharma IPO has begun on 25-Apr-2023. It will close on 27-Apr-2023. The Total IPO Size is 4,326.36 Crore. The company set its IPO price is 1026-1080 Rs Per Share. Basically, there are three basic categories in Mankind Pharma IPO Subscription 1) Qualified Institutional Buyers 2) Non-Institutional Investors 3) Retail Individual Investors (RIIs).

Mankind Pharma is Majorly know for it’s Product “Manforce condoms”. Mankind Pharma is a India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022.

They are engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

The 97.60% total revenue comes from the Domestic market. They have created 36 brands in thier pharmaceutical business that have each achieved over ₹500.00 million in FY22.

They have several differentiated brands in the condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories.

Latest News Update: Mankind Pharma IPO Subscription Status Live
  • Mankind Pharma IPO subscribed 15.32 times, retail portion booked 0.92 times on day 3 day.
  • The QIB 49.16, NII 3.80 times Subscribed on day 3.

Mankind Pharma IPO Subscription Status

Day 1 (times) Day 2 (times) Day 3 (times)
QIB 0.08 1.86 49.16
NII 0.33 1.02 3.80
Retail 0.10 0.25 0.92
Total 0.14 0.88 15.32

Leave a Reply